ALSERES PHARMACEUTICALS INC /DE
DelistedCIK 94784fmd_07VPHV5VJS5TRN1DJSCJQBN0GEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2007 to Jun 30, 2014, 20 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | 1 | 0 |
| Net interest income | – | – | – | – | – | (0) | (0) |
| Research and development | – | – | – | 0 | 0 | 0 | – |
| Total operating expenses | – | – | – | 3 | 2 | 2 | 1 |
| Operating income | – | – | – | (3) | (2) | (1) | (1) |
| Interest expense | – | – | – | 3 | 2 | 0 | – |
| Interest and investment income | – | – | – | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | 0 | 0 | 0 |
| Net income | (20) | (21) | (11) | 1 | (3) | (2) | (1) |
| Net income to common shareholders | – | – | – | 0 | (3) | (2) | (1) |